HbA1c is the world’s most widely used test for diagnosing type 2 diabetes. New evidence shows that G6PD deficiency and other genetic variants are systematically distorting its results for Black and ...

Potential fallout from the recent UK Biobank data exposure – and similar cases – highlights that governance cannot be treated as an administrative add on. It is foundational infrastructure on which ...

Quantum computing, a type of quantum technology, is poised to address pressing challenges in the healthcare sector. For example, while the average cost of the drug development pipeline has tripled ...

Following the successful completion of the NHS national pilot in April 2025, the highly anticipated first results assessing CYP2C19 genetic testing to guide clopidogrel use in ischaemic stroke and TIA ...

Our conferences, roundtables, workshops and seminars are attended by leaders and senior professionals working at the interface of science, research, policy and healthcare. Free to attend, our events ...

Catherine Barnard, FBA, FLSW, FRSA is Professor of European law and fellow of Trinity College, Cambridge and Director of the Centre for European Legal Studies. She is the author of EU Employment Law ...

Patricia is a policy analyst in the humanities team, specializing in the legal and ethical frameworks governing scientific health innovations, and the health data governance structures that support ...

Polygenic scores are a source of considerable debate in the biomedical and healthcare communities. Can they or can they not provide information that can be used in the prevention of common complex ...

The sepsis definition describes three elements: infection, the host response and life-threatening organ dysfunction. Diagnosis is made based on myriad signs and symptoms, and although infection ...

Sepsis is a critical global healthcare challenge, marked by complex and rapidly evolving symptoms, which can escalate with alarming speed leading to multi-organ failure. This leaves only a narrow ...

Cost-utility studies provide critical information for the costs and benefits of using any new test, typically building on existing public health and screening programmes, within a defined population.

Synthetic data is artificially generated data that reflects the properties and relationships found in real data. While synthetic data can play an important role in AIaMD development, its use in ...